多烯磷脂酰胆碱联合依那普利治疗高血压病合并非酒精性脂肪性肝病的临床观察

Clinical Observation on Polyunsaturated Phosphatidylcholine Combined with Enalapril in Treatment of Hypertension Complicated with Non-Alcoholic Fatty Liver Disease

目的:观察多烯磷脂酰胆碱联合依那普利治疗高血压病合并非酒精性脂肪性肝病的疗效。方法:将高血压合并非酒精性脂肪肝患者76例,随机分为两组,治疗组予以多烯磷脂酰胆碱联合依那普利治疗,对照组予以依那普利治疗,12周后评定疗效。结果:有效率治疗组为76.3%,对照组为55.39%,两组比较差异有统计学意义(P<0.05)。结论:多烯磷脂酰胆碱联合依那普利治疗高血压合并非酒精性脂肪肝疗效显著。

Objective： To observe the efficacy of polyunsaturated phosphatidylcholine combined with enalapril in treatment of hypertension complicated with non-alcoholic fatty liver disease. Methods： Seventy-six patients with hypertension complicated with fatty liver were randomly divided into a treatment group and a control group. The treatment group was treated by polyunsaturated phosphatidylcholine combined with enalapril and the control group was treated by enalapril. The efficacy was evaluated after 12 weeks. Results： The efficiency rate of the treatment group was 76.3% and the control group was 55.39%. There was statistically significance compared the difference between the two groups （ P 〈 0.05 ）. Conclusion ： Polyunsaturated phosphatidylcholine combined with enalapril is of significant curative effect in treatment of hypertension complicated with non-alcoholic fatty liver disease.